BCR Antikörper (AA 1042-1243)
-
- Target Alle BCR Antikörper anzeigen
- BCR (Breakpoint Cluster Region (BCR))
-
Bindungsspezifität
- AA 1042-1243
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- Spezifität
- The antibody is a rabbit polyclonal antibody raised against BCR. It has been selected for its ability to recognize BCR in immunohistochemical staining and western blotting.
- Aufreinigung
- Antigen-specific affinity chromatography
- Immunogen
- BCR (Arg1042-Val1243)
- Isotyp
- IgG
- Top Product
- Discover our top product BCR Primärantikörper
-
-
- Applikationshinweise
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
- Target
- BCR (Breakpoint Cluster Region (BCR))
- Abstract
- BCR Produkte
- Hintergrund
- Alternative Names: ALL, BCR/FGFR1, BCR1, CML, FGFR1/BCR, PHL, Renal carcinoma antigen NY-REN-26
- Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
-